Diabetes
Jardiance cost with insurance.
Jardiance (empagliflozin) costs $25–$95/month for most commercially insured patients in 2026, with a manufacturer savings card available, and a $35/month Medicare cap for diabetes patients under the Inflation Reduction Act.
Sample data — not yet verifiedNo prior authTier 3
$678
List price (1 month)
$612
Cash discount
$571
Mail order
Related medications
See how Jardiance compares
FAQ
Jardiance cost questions
Why is Jardiance so expensive?
Jardiance is a brand-name diabetes medication, list price ~$678/month, because it's still under patent — generics aren't yet available. Insurance can bring this down significantly once your deductible is met.
Does insurance cover it?
Most major insurance plans cover Jardiance as a Tier 3 drug. Coverage varies by plan — use the calculator above for a plan-specific estimate.
Is there a generic for Jardiance?
No generic for empagliflozin is currently FDA-approved. The closest cost-saving options are manufacturer self-pay programs, which can drop the price to around $571/month for eligible patients.
What if my insurance denies it?
If your prior authorization is denied, options include: appealing with your prescriber, switching to a similar covered drug in the same therapeutic class, or using the manufacturer's self-pay program. The calculator above shows all four payment paths.
Data sources
Source URLs for Jardiance have not yet been verified. Estimates below are modeled from general public pricing patterns.
- • Manufacturer published pricing pages
- • NADAC National Average Drug Acquisition Cost
- • Carrier-published formulary tiers (where known)
- • Cost Plus Drugs / mail-order public pricing
- • FDA Orange Book (generic availability)